FORTRESS BIOTECH INC - COM (FBIO)

CUSIP: 34960Q109

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
8,435,451
Share change
+811,172
Total reported value
$13,710,475
Price per share
$1.60
Number of holders
60
Value change
+$747,616
Number of buys
29
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 34960Q109?
CUSIP 34960Q109 identifies FBIO - FORTRESS BIOTECH INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FORTRESS BIOTECH INC - COM (FBIO) as of Q3 2018

As of 30 Sep 2018, FORTRESS BIOTECH INC - COM (FBIO) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,435,451 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, Granite Point Capital Management, L.P., DEUTSCHE BANK AG\, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STRS OHIO, and Opus Point Partners Management, LLC. This page lists 60 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.